DK134906C - - Google Patents

Info

Publication number
DK134906C
DK134906C DK619172A DK619172A DK134906C DK 134906 C DK134906 C DK 134906C DK 619172 A DK619172 A DK 619172A DK 619172 A DK619172 A DK 619172A DK 134906 C DK134906 C DK 134906C
Authority
DK
Denmark
Application number
DK619172A
Other languages
Danish (da)
Other versions
DK134906B (da
Inventor
A Holmes
R F Meyer
Original Assignee
Parke Davis & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis & Co filed Critical Parke Davis & Co
Publication of DK134906B publication Critical patent/DK134906B/da
Application granted granted Critical
Publication of DK134906C publication Critical patent/DK134906C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK619172AA 1971-12-14 1972-12-12 Analogifremgangsmåde til fremstilling af 1-(3,4-dimethoxyphenethylamino)-3(substitueret phenoxy)-2-propanoler. DK134906B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00207954A US3857891A (en) 1971-12-14 1971-12-14 New aminoalkanol compounds and methods for their production

Publications (2)

Publication Number Publication Date
DK134906B DK134906B (da) 1977-02-07
DK134906C true DK134906C (en:Method) 1977-06-27

Family

ID=22772656

Family Applications (1)

Application Number Title Priority Date Filing Date
DK619172AA DK134906B (da) 1971-12-14 1972-12-12 Analogifremgangsmåde til fremstilling af 1-(3,4-dimethoxyphenethylamino)-3(substitueret phenoxy)-2-propanoler.

Country Status (21)

Country Link
US (1) US3857891A (en:Method)
JP (1) JPS5233621B2 (en:Method)
AR (2) AR195896A1 (en:Method)
AT (1) AT317182B (en:Method)
AU (1) AU475446B2 (en:Method)
BE (1) BE790165A (en:Method)
CA (1) CA993889A (en:Method)
CH (1) CH551371A (en:Method)
DK (1) DK134906B (en:Method)
ES (1) ES409565A1 (en:Method)
FI (1) FI55650C (en:Method)
FR (1) FR2163486B1 (en:Method)
GB (1) GB1344976A (en:Method)
HU (1) HU164953B (en:Method)
IE (1) IE37701B1 (en:Method)
IL (1) IL40833A (en:Method)
NL (1) NL150101B (en:Method)
NO (1) NO135244C (en:Method)
SE (1) SE393104B (en:Method)
YU (2) YU35871B (en:Method)
ZA (1) ZA727078B (en:Method)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2119843B1 (en:Method) * 1970-12-28 1974-03-22 Laroche Navarro Labo
JPS5653534B2 (en:Method) * 1973-10-25 1981-12-19
SE388849B (sv) * 1974-02-14 1976-10-18 Haessle Ab Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
US4080471A (en) * 1976-06-25 1978-03-21 Aktiebolaget Hassle Use of substituted isopropylaminopropanols for inducing inotropic effects of the human heart
JPS56158868A (en) * 1980-05-13 1981-12-07 Satake Eng Co Ltd Ion nitriding treatment device
ZA852843B (en) * 1984-05-15 1985-11-27 Warner Lambert Co Bevantolol preparation
US5095151A (en) * 1985-05-21 1992-03-10 American Home Products Corporation Preparation of propranolol hydrochloride macrocrystals
US4789751A (en) * 1985-10-01 1988-12-06 University Patents, Inc. Synthesis of new liquid crystal materials possessing phenylbenzoate or biphenyl core units and (2,3)-epoalkyloxirane methanol chiral tails
JP2587336B2 (ja) * 1991-10-03 1997-03-05 日本ケミファ株式会社 塩酸ベバントロールの製造方法
US5482964A (en) * 1994-10-11 1996-01-09 Warner-Lambert Company Substituted phenoxyhydroxypropyl amines as central nervous system agents
TW467881B (en) * 1997-07-31 2001-12-11 Ying-Jiun Chen Guaiacoxypropanolamines with Α/β-adrenergic blocking activity
WO2000005193A1 (en) * 1998-07-23 2000-02-03 Chen Ing Jun GUAIACOXYPROPANOLAMINE DERIVATIVES WITH α/β-ADRENERGIC BLOCKING ACTIVITY
MXPA05001958A (es) 2002-08-19 2005-04-28 Pfizer Prod Inc Terapia de combinacion para enfermedades hiperproliferativas.
JP4901474B2 (ja) 2003-05-30 2012-03-21 ランバクシー ラボラトリーズ リミテッド 置換ピロール誘導体
CN1884251B (zh) * 2005-06-22 2010-06-23 北京德众万全医药科技有限公司 一种盐酸贝凡洛尔的精制方法
US8026377B2 (en) 2005-11-08 2011-09-27 Ranbaxy Laboratories, Limited Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
AU2014283319B2 (en) * 2013-06-19 2019-07-25 Som Innovation Biotech, S.L. Therapeutic agents for use in the prophylaxis and/or treatment of hyperkinetic movement disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL300886A (en:Method) * 1962-11-23
NL301580A (en:Method) * 1962-12-11
GB1069343A (en) * 1963-09-10 1967-05-17 Ici Ltd Propanolamine derivatives

Also Published As

Publication number Publication date
YU293979A (en) 1981-04-30
IL40833A (en) 1976-01-30
US3857891A (en) 1974-12-31
SE393104B (sv) 1977-05-02
FR2163486B1 (en:Method) 1976-03-05
AU475446B2 (en) 1976-08-26
DK134906B (da) 1977-02-07
NL7216281A (en:Method) 1973-06-18
IL40833A0 (en) 1973-01-30
ZA727078B (en) 1973-06-27
YU35871B (en) 1981-08-31
ES409565A1 (es) 1975-12-01
AT317182B (de) 1974-08-12
IE37701B1 (en) 1977-09-28
NO135244B (en:Method) 1976-11-29
AU4918672A (en) 1974-05-23
AR198442A1 (es) 1974-06-21
JPS5233621B2 (en:Method) 1977-08-30
JPS4867232A (en:Method) 1973-09-13
DE2259489B2 (de) 1976-02-26
AR195896A1 (es) 1973-11-15
BE790165A (fr) 1973-02-15
CH551371A (fr) 1974-07-15
FR2163486A1 (en:Method) 1973-07-27
NO135244C (en:Method) 1977-03-09
FI55650C (fi) 1979-09-10
CA993889A (en) 1976-07-27
GB1344976A (en) 1974-01-23
HU164953B (en:Method) 1974-05-28
IE37701L (en) 1973-05-14
YU36007B (en) 1981-11-13
DE2259489A1 (de) 1973-07-05
FI55650B (fi) 1979-05-31
NL150101B (nl) 1976-07-15
YU301972A (en) 1981-02-28

Similar Documents

Publication Publication Date Title
CS175429B2 (en:Method)
CS174858B2 (en:Method)
FR2163486B1 (en:Method)
CS170286B1 (en:Method)
CS176132B2 (en:Method)
CS174186B2 (en:Method)
FR2145377A1 (en:Method)
CS177829B2 (en:Method)
CS156864B1 (en:Method)
AU428077B2 (en:Method)
CS154961B1 (en:Method)
CS165283B1 (en:Method)
CS155926B1 (en:Method)
CS148656B1 (en:Method)
CS149246B1 (en:Method)
CS150433B1 (en:Method)
CS152635B1 (en:Method)
CS154074B1 (en:Method)
CS154113B1 (en:Method)
CS162458B1 (en:Method)
CS160771B1 (en:Method)
CS162518B1 (en:Method)
BG16669A1 (en:Method)
BE785307A (en:Method)
BG17050A1 (en:Method)

Legal Events

Date Code Title Description
PUP Patent expired